Multi-cohort Investigational Study to Evaluate the Impact of Pelvic Mp-3TMRI and Whole-body 68Ga-PSMA PET/CT for Diagnosis of Clinically-significant Prostate Cancer and Pre-surgical Staging.
Phase of Trial: Phase III
Latest Information Update: 20 Nov 2018
At a glance
- Drugs Gallium 68 PSMA (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- Acronyms BIOPSTAGE
- 08 Nov 2018 Status changed from not yet recruiting to recruiting.
- 16 Mar 2018 New trial record